l e n g t h (1.1.1.) b u t t h e v a r i a b r l l t y might l i m i t i t s u s e f u l n e s s f o r growth s t u d i e s . T h i s was investigated by performing 12 c o n s e c u t i v e weekly knemometric s e s s i o n s (each consisting of 6 measurcments) and 4-weekly s t a d i o m c t r y on 31 h e a l t h y c h i l d r e n of 6-12.5 y e a r s of age. The average SD of 6 measurements was 0.12 mm. A r e g r e s s i o n ( l i n e a r and 4 o r t h o g o n a l polynomials) was computed of 1.1.1. on time. The r e s i d u a l mean s q u a r e was much h l g h e r t h a n t h e v a r l a n c e w i t h i n 6 measurements. The l i n e a r r e g r e s s i o n was s i g n i f i c a n t a t 0.05 l e v e l i n 29 c h i l d r e n . Average (iSD) 1.1.1. growth v e l o c i t y was 0.3Gf0.14 mm/week, and h e i g h t 1.27i0.54 mm/week @-atlo 3.9f2.G). The Znd, 3rd, and 4 t h polynomials were s i g n i f i c a n t more o f t e n than expected l f h i g h e r o r d e r e f f e c t s would b e a b s e n t . When growth vel o c i t i e s were c a l c u l a t e d o v e r t h e f i r s t 6 weeks (v ) and l a s t 6 weeks ( v ) , v and v were d i f f e r e n t from z e r o i n 43 and 19 c h l ldren. ~e i n f AD of t 2 e 31 v v a l u e s were 0.39 and 0.15 -/week. was s i g n i f i c a n t l y d i f k e r e n t from z e r o i n 5 c h i l d r e n . Mean f 3-2 t h e 31 v -v v a l u e s were -0.051?0.23 mm/week. I f a one-side 2 1 t e s t i s used, a d l f f e r c n c e v2-v1 g r e a t e r t h a n 0.37 mm/week i s s l gn l f i c a n t . T h i s c o r r e s p o n d s wlth a s t a t u r a l growth response of 7. of Cadiz ( S p a i n ) and Zurich ( S w i t z e r l a n d ) .
ARCUMENTAL-MODULE METHOD FOR THE STUDY OF BONE ACE (BA)
The most a c c e p t e d numerical method f o r t h e a s s e s s m e n t of BA i s Tanner -Whitehouse (TW2 ) . However, i t s d i s a d v a ntage i s t h a t i t i s l a b o r i o u s and r e q u i r e s t r a i n e d s t a f f . A method b a s e d on computer a n a l y s i s of bone s h a p e a s i (IC= integrated concentration; AUC= area under the curve) Fasting serum IGF-1 levels were elevated in 2 girls aged 11 (37 nM/1) and 15 yrs (48 nM/1), and within the normal range in the rest of the sibs (16-43 nM/l), and in the parents (16.5 & 24.2 nM/l), with a si nificant correlation to their basal GH levels (r=.85, p< .02q.
n d i c a t o r of m a t u r i t y h a s been d e v e l o p e d . The r e p r e s e n t a t iv e p a t t e r n s of e a c h m a t u r i t y s t a g e of t h e TW2 a t l a s h a v e been d i g i t i z e d b y means of a g r a p h i c b o a r d . T h e computer c a l c u l a t e s t h e g r a v i t y c e n t e r of t h e f i g u r e s and r e p r e s e n t e s t h e v e c t o r i a l r a d i u s from t h e c e n t e r of g r a v i t y t o t h e point of t h e bone p e r i m e t e r f o r e a c h d i g i t i z e d point on a c o o r d i n a t e a x i s . T h e d e g r e e s of e a c h v e c t o r (0-360Q) c o r r e s p o n d t o a x i s X and t h e length of e a c h v e c t o r to a x i s Y . T h e unified e x t r e m e s of t h e v e c t o r s r e s u l t in a r e p r e s e n t a t i v e c u r v e of t h e bone s h a p e . T h e comparison of a problem c u r v e w i t h t h e catalogue of s t a n d a r d c u r v e s of TW2 a t l a s h a s demonstrated t h a t t h i s method i s e a s i e r t h a n t h e c l a
In conclusion, the pattern of GH secretion in several members of a family with tall stature was reported. In all the siblings an abnormal GH response to TRH and in 3 tested an increased daily output of GH was found. 1022-1026.1984) .We have treated 15 girls and 5 boys (chron.age 10.1-14.6 years. bone age 11.0-14.9 years) with bro~criptine (2~2.5 mglday) over a period of 1.14 -0.31 years (0.6-1.75).
Results (paired Wi lcoxon rank test) : The differences between the mean adult height prediction before and after bromocriptine were -0.8 ' 3.5 cm according to Bailey-Pinneau (p = 0.433) and t0.2 ' 2.5 cm according to Tanner Mark 1 (p = 0.586). The mean peak $H values after TRH i .v. were 53.0 ' 50.2 mU/1 before. and 59.0 -50.2 mull during bromocriptine treatment (p = 0.314). The wide range of the GH results most probably reflects physiological variations in this age group. Our results are essentially negative. Moreover. the concept. that bromocriptine reduces GH secretion. seems doubtful: in 6 of our patients we have measured plasma GH after 2.5 mg of bromocriptine and found a significant increase within the first three hours.
Our results do not support the data from the literature. We conclude that bromocriptine is ineffective in reducing adult height of tall girls and boys. Supported by Swiss National Science Foundation grant 3.906 083. By contrast, differences in HP-TWII were not significant. Because of this discrepancy it is uncertain whether final height in tall boys will really be reduced by treatment with BRC. BRC was kindly provided by Dr. R. Schmidt, Sandoz Ltd.
